Arixtra (Fondaparinux Sodium)- FDA | | Drug | Target | Antithrombin | | | | | | |
Chronic Lymphocytic Leukemia | | Disease | Drug | Alemtuzumab (Campath)- FDA | | | | | | |
Acute Promyelocytic Leukemia | | Disease | Target | Retinoic Acid Receptor Alpha | | | | | | |
Anxiety | | Disease | Target | Neuropeptide S Receptor | | | | | | |
Cancer | | Disease | Target | Kallikrein-6 | | | | | | |
BAFF | | Target | Target | BLyS | | | | | | |
CINC-2- alpha | | Target | Disease | Inflammation | | | | | | |
Abatacept (Orencia)- FDA | | Drug | Disease | Rheumatoid Arthritis | | | | | | |
Avastin (Bevacizumab)- FDA | | Drug | Drug | Aflibercept (Eylea)- FDA | | | | | | |
Irritable Bowel Syndrome | | Disease | Drug | Alosetron Hydrochloride (Lotronex)- FDA | | | | | | |